Assessing the Severity of Type 2 Diabetes Using Clinical Data Derived Metrics: a Systematic Review
暂无分享,去创建一个
M. Rutter | I. Buchan | C. Chew‐Graham | N. Peek | C. Salisbury | E. Kontopantelis | C. Mallen | M. Mamas | D. Ashcroft | N. Qureshi | M. Panagioti | S. Zghebi | H. Marwijk | Salwa S Zghebi
[1] Geltrude Mingrone,et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetes Care.
[2] M. Woodward,et al. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register , 2018, Diabetes Care.
[3] Evangelos Kontopantelis,et al. Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design , 2018, BMJ Open.
[4] Evangelos Kontopantelis,et al. Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study , 2018, BMJ Open.
[5] Min Zhang,et al. Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity , 2018, Experimental and therapeutic medicine.
[6] Deepak L. Bhatt,et al. Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity , 2017, Annals of surgery.
[7] C. Jack,et al. Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) , 2017, Diabetes Care.
[8] J. Brazier,et al. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies. , 2017, Investigative ophthalmology & visual science.
[9] W. Glasheen,et al. Diabetes Complications Severity Index (DCSI)-Update and ICD-10 translation. , 2017, Journal of diabetes and its complications.
[10] M. Schuemie,et al. Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: a validation study , 2016, BMJ Open.
[11] T. Vilsbøll,et al. Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study , 2016, BMC Health Services Research.
[12] Jamaluddin Moloo,et al. ADA Standards of Medical Care in Diabetes , 2016 .
[13] S. Reilly,et al. Modelling Conditions and Health Care Processes in Electronic Health Records: An Application to Severe Mental Illness with the Clinical Practice Research Datalink , 2016, PloS one.
[14] I Buchan,et al. Combining Health Data Uses to Ignite Health System Learning , 2015, Methods of Information in Medicine.
[15] K. Insel,et al. Severity of Type 2 Diabetes, Cognitive Function, and Self-Care , 2015, Biological research for nursing.
[16] N. Runkel,et al. Downgrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter , 2015, Obesity Surgery.
[17] Tyler Williamson,et al. Validation of the Diagnostic Algorithms for 5 Chronic Conditions in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN): A Kingston Practice-based Research Network (PBRN) Report , 2013, The Journal of the American Board of Family Medicine.
[18] N. Skolnik,et al. Management of Hyperglycemia in Type 2 Diabetes , 2012 .
[19] R. Mcdermott,et al. A simple diabetes vascular severity staging instrument and its application to a Torres Strait Islander and Aboriginal adult cohort of north Australia , 2012, BMC Health Services Research.
[20] S. Stapley,et al. The use of electronic databases in primary care research. , 2011, Family practice.
[21] P. Rose,et al. Validity of diagnostic coding within the General Practice Research Database: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[22] K. Ichihara,et al. Exploration of hematological and immunological changes associated with the severity of type 2 diabetes mellitus in Japan. , 2008, Nursing & health sciences.
[23] W. Katon,et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.
[24] Janet E Hux,et al. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study , 2007, The Lancet.
[25] Yoshifumi Naka,et al. Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database , 2006, Circulation.
[26] D. Malone,et al. Development and Validation of a Diabetes Mellitus Severity Index: A Risk‐Adjustment Tool for Predicting Health Care Resource Use and Costs , 2005, Pharmacotherapy.
[27] Donald R. Miller,et al. Preliminary Validation of a Patient‐based Self‐assessment Measure of Severity of Illness in Type 2 Diabetes: Results From the Pilot Phase of the Veterans Health Study , 2005, The Journal of ambulatory care management.
[28] Abdullah Alkenizan,et al. Innovative care for chronic conditions: building blocks for action , 2004, Annals of Saudi Medicine.
[29] Robert L. McCarthy,et al. Introduction to Health Care Delivery: A Primer for Pharmacists , 2003 .
[30] S. Kaplan,et al. The Association between Three Different Measures of Health Status and Satisfaction among Patients with Diabetes , 2003, Medical care research and review : MCRR.
[31] K. Weinger,et al. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. , 2002, The American journal of managed care.
[32] H. Bilo,et al. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1) , 2002, European Journal of Epidemiology.
[33] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[34] F J Snoek,et al. Development of a Type 2 Diabetes Symptom Checklist: a Measure of Symptom Severity , 1994, Diabetic medicine : a journal of the British Diabetic Association.
[35] C. Tse,et al. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. , 1993, Journal of clinical epidemiology.
[36] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[37] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.
[38] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.